Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Biol Trace Elem Res ; 39(2-3): 149-59, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-7509172

RESUMEN

In six chronic dialyzed uremic patients, an intravenous sodium selenite (Se 50 micrograms during 5 wk and then 100 micrograms) and zinc gluconate (Zn 5 mg) supplementation was performed during 20 wk at each dialysis session three times weekly. Before supplementation, plasma Se and Zn, plasma and erythrocytes (RBC) antioxidant metallo-enzymes glutathione peroxidase (GPX), and superoxide dismutase (SOD) were significantly decreased, whereas lipid peroxidation (as thiobarbituric acid reactants TBARs) was increased. To obtain a significative change in plasma selenium, we had to use an Se dose of 100 micrograms/dialysis session. Then, treatment-increased plasma Se (from 0.58 +/- 0.09 to 0.89 +/- 0.16 mumol/L) led to a repletion of RBC-GPX (from 29.6 +/- 6 to 43 +/- 5.8 U/g Hb) and increased plasma GPX levels (from 62 +/- 13 to 151 +/- 43 U/L). Plasma Zn and RBC-SOD did not vary significantly. The change of TBARs was not observed between wk 1 and 4. They decreased significantly between wk 4 (4.80 +/- 0.21 mumol/L) and wk 20 (4.16 +/- 0.26 mumol/L). We noted a low correlation between TBARs and plasma GPX. A strong correlation was observed between Se and plasma GPX. The reversal of Se deficiencies should reduce oxidative damage observed in these patients.


Asunto(s)
Gluconatos/farmacología , Diálisis Renal/efectos adversos , Selenio/deficiencia , Selenito de Sodio/farmacología , Zinc/deficiencia , Anciano , Análisis de Varianza , Eritrocitos/enzimología , Femenino , Gluconatos/administración & dosificación , Glutatión Peroxidasa/sangre , Humanos , Inyecciones Intravenosas , Peroxidación de Lípido/efectos de los fármacos , Masculino , Persona de Mediana Edad , Selenio/sangre , Selenito de Sodio/administración & dosificación , Superóxido Dismutasa/sangre , Uremia/metabolismo , Zinc/sangre
3.
Am J Clin Nutr ; 57(4): 566-72, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8460613

RESUMEN

Forty-four institutionalized elderly subjects with body mass indexes (BMI) of either > or = 24 or < or = 21 participated in a 16-wk crossover study designed to determine the effects of low-dose zinc supplementation [306 mumol (20 mg)/d] on food intake, anthropometry, and biochemical and immunological indexes. Initial serum zinc concentrations were low in both groups and increased by approximately 20% after zinc supplementation. Zinc supplementation allowed a partial but significant restoration of serum thymulin activity and improved nutritional status (food intake and serum albumin and transthyretin concentrations) but had no effect on anthropometric indexes or serum apolipoproteins, except apolipoprotein CII and apolipoprotein CIII. After zinc supplementation, serum copper concentration decreased but there was no change in the ratio of low-density-lipoprotein cholesterol to high-density-lipoprotein cholesterol. Low-dose zinc supplementation allows restoration, at least partially, of nutritional and thymic status without the known disadvantages of high doses of zinc.


Asunto(s)
Ingestión de Alimentos/fisiología , Zinc/farmacología , Anciano , Anciano de 80 o más Años , Antropometría , Índice de Masa Corporal , Femenino , Humanos , Lípidos/sangre , Masculino , Estado Nutricional , Hormonas del Timo/fisiología
4.
Ann Pharm Fr ; 51(6): 273-82, 1993.
Artículo en Francés | MEDLINE | ID: mdl-8154796

RESUMEN

Patients treated with chronic parenteral nutrition develop metabolic bone diseases. Because of the chemical relationship between barium and calcium, and the barium bone affinity, a possible responsibility of this element in this bone pathology has been searched. The study of the different parenteral nutrition components shows that significant concentrations of barium have been found in total parenteral nutrition bags.


Asunto(s)
Bario/análisis , Contaminación de Medicamentos , Solución Hipertónica de Glucosa/química , Osteoporosis/inducido químicamente , Nutrición Parenteral/efectos adversos , Bario/efectos adversos , Química Farmacéutica , Solución Hipertónica de Glucosa/efectos adversos , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro
5.
Biol Trace Elem Res ; 32: 405-14, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1375082

RESUMEN

The effect of a multivitamin-mineral supplement was investigated during pregnancy according to a double-blind protocol by determining zinc and copper in maternal plasma, mononuclear and polynuclear zinc and copper at the third, sixth, eighth, and ninth months of gestation. The subjects were supplemented from the first trimester until delivery. A significant decrease was observed in plasma zinc that varied from 11.5 mumol/L to 10.8 mumol/L in the supplemented group (n = 29) and from 11 mumol/L to 10 mumol/L in the placebo group (n = 33) at 3 and 9 mo of gestation, respectively. In contrast, plasma copper levels increased in a way depending upon the stage of gestation in both groups: from 24.7 to 28.2 mumol/L in the treated group and from 24.9 to 30.9 mumol/L in the placebo group at 3 and 9 mo of gestation, respectively, but the difference was only significant in the placebo group. No difference between groups was observed in mononuclear and polynuclear zinc or copper levels. These trace elements were also determined in cord blood at delivery. There were no statistically significant differences in zinc and copper concentration found in placebo group and supplemented group. Finally, the beneficial effect of supplementation on muscular cramps and appearance of vergetures was noted.


Asunto(s)
Cobre/farmacología , Embarazo/efectos de los fármacos , Vitaminas/farmacología , Zinc/farmacología , Adolescente , Adulto , Cobre/efectos adversos , Cobre/metabolismo , Método Doble Ciego , Femenino , Humanos , Estado Nutricional , Embarazo/metabolismo , Embarazo/fisiología , Complicaciones del Embarazo/etiología , Complicaciones del Embarazo/metabolismo , Zinc/efectos adversos , Zinc/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...